17/12/2025
Improving lung cancer outcomes sometimes starts with people sitting together differently.
In the Philippines, Dr. Herdee Luna has been working with pathologists, patient advocates, medical societies, and diagnostic partners to tackle a very practical problem: why biomarker testing for lung cancer takes too long—and what can realistically be done about it.
Rather than jumping straight to solutions, the group mapped the patient journey, identified where delays and breakdowns occur, and focused on what healthcare teams could change now:
better coordination, clearer testing pathways, and practical training to improve tissue adequacy and turnaround times.
One outcome was a multidisciplinary training, co-created with local medical societies, reaching more than 250 healthcare professionals. Another was something less visible but just as important: shared ownership across specialties.
What’s striking about this work is that many countries are facing the same challenges—and could adapt a similar approach in their own context.
If you’re working on:
• improving access to biomarker testing
• strengthening multidisciplinary collaboration
• translating precision medicine into day-to-day care
…you’re not alone.
There’s a growing community of clinicians, patient leaders, and system actors comparing notes, sharing tools, and learning from country pilots like this one.
FT3 exists quietly in the background of that work—as a neutral space to connect people who are trying to make similar changes in different settings.
👉 If Dr Luna’s experience resonates, or if you’re exploring a similar effort in your country, feel free to reach out or explore the FT3 community. Sometimes progress starts by finding the right peers, not reinventing the wheel.
🔗 Read the full article here: https://eu1.hubs.ly/H0qvhKz0
Tags - Emer Rojas | Dr. Jasper Andal | Wilfred So Chua | Allan Marx Ancheta | Jeanie Hsieh | Stephanie Dy | Kriska Lim | Estela del Rosario | Reymel Salvatus | Vanessa Ongsue | Isha Jerath
